Withings has introduced a new health tech device at CES this year, the BeamO, priced at $249.95. BeamO is a multiscope that combines several health monitoring functions into one device. It measures temperature, takes electrocardiograms (EKGs), reads blood oxygen levels, and functions as a stethoscope to monitor heart and lung health.
Key features of the BeamO include:
- Multifunctional Capabilities: The device is equipped with photoplethysmography (PPG) sensors, electrodes, a digital stethoscope, and an advanced infrared temperature sensor. These components enable it to perform a variety of health measurements.
- EKG and Pulse Oximetry: BeamO has electrodes on its sides for EKG readings, which can detect atrial fibrillation. It also measures blood oxygen levels using PPG sensors, similar to those found in most smartwatches.
- Stethoscope Functionality: The inclusion of a piezoelectric disc allows BeamO to function as a stethoscope. This disc captures acoustic noise from the chest or back and converts it into an electric signal that the device can read.
- Telehealth Compatibility: The device can be used in telehealth sessions, allowing audio streaming directly to healthcare providers. It also comes with a USB-C to headphone jack adapter for listening before transferring audio to the Withings app.
- FDA Clearance: The EKG and AFib detection features of BeamO will need to undergo the FDA clearance process. Withings expects the device to go on sale in June this year, although there have been delays in FDA clearance for previous Withings products.
The BeamO represents Withings’ continued investment in developing an at-home health platform, aiming to simplify and enhance health monitoring for families. However, the actual availability of the device is subject to FDA approval, and Withings has a history of delays in getting clearance for its innovative health tech products.